JPMorgan Chase & Co. decreased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 6.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,630,803 shares of the company’s stock after selling 167,935 shares during the period. JPMorgan Chase & Co. owned 1.12% of Cardinal Health worth $540,630,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. Aventura Private Wealth LLC bought a new position in shares of Cardinal Health during the 4th quarter worth approximately $25,000. Jones Financial Companies Lllp increased its stake in shares of Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares in the last quarter. Palladiem LLC bought a new stake in shares of Cardinal Health in the 4th quarter valued at $28,000. JPL Wealth Management LLC acquired a new position in shares of Cardinal Health during the 3rd quarter valued at $31,000. Finally, Turning Point Benefit Group Inc. acquired a new position in shares of Cardinal Health during the 3rd quarter valued at $31,000. Institutional investors and hedge funds own 87.17% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on CAH shares. Citigroup reduced their price target on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a report on Friday, May 1st. Barclays raised their target price on Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, February 24th. Leerink Partners reaffirmed an “outperform” rating and issued a $275.00 target price on shares of Cardinal Health in a research report on Monday, March 9th. TD Cowen upped their price target on Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a research note on Friday, May 1st. Finally, Zacks Research upgraded Cardinal Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 12th. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $246.93.
Cardinal Health Trading Up 1.5%
Cardinal Health stock opened at $215.77 on Thursday. The firm has a market capitalization of $50.54 billion, a price-to-earnings ratio of 32.99, a price-to-earnings-growth ratio of 1.16 and a beta of 0.52. The firm’s fifty day moving average price is $202.77 and its two-hundred day moving average price is $208.66. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $233.60.
Cardinal Health (NYSE:CAH – Get Free Report) last posted its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The company had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. During the same quarter in the prior year, the business posted $2.35 EPS. The firm’s revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, research analysts forecast that Cardinal Health, Inc. will post 10.76 EPS for the current year.
Cardinal Health Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. This represents a $2.06 annualized dividend and a dividend yield of 1.0%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. Cardinal Health’s dividend payout ratio (DPR) is currently 31.19%.
Cardinal Health Profile
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Featured Articles
- Five stocks we like better than Cardinal Health
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
